Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Elens

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Pharmacogenetics and Genomics|September 22, 2007
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantationLaure Elens, Arnaud Capron, Valérie Van Kerckhove, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 30, 2020
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectivesAlexandra L Degraeve, Serge Moudio, Vincent Haufroid, et al.
Therapeutic Drug Monitoring|October 17, 2022
Genetic Polymorphisms in SLCO2B1 and ABCC1 Conjointly Modulate Atorvastatin Intracellular Accumulation in HEK293 Recombinant Cell LinesEmilia Hoste, Adrien Paquot, Nadtha Panin, et al.
Microbiome|July 5, 2023
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1Alexandra L Degraeve, Vincent Haufroid, Axelle Loriot, et al.
Scientific Reports|May 11, 2018
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patientsLeïla Belkhir, Carole Seguin-Devaux, Laure Elens, et al.
Pharmacogenomics|September 10, 2011
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patientsLaure Elens, Ron H van Schaik, Nadtha Panin, et al.
Pharmacogenomics|February 23, 2018
Detection of a rare CYP3A4 variant in a transplant patient characterized by a tacrolimus poor metabolizer phenotypeNuria Lloberas, Dennis A Hesselink, Ron Hn van Schaik, et al.
Clinical and Translational Science|November 11, 2021
Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical responseGabriel Stillemans, Adrien Paquot, Giulio G Muccioli, et al.
The Journal of Surgical Research|July 28, 2012
Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantationMartine De Meyer, Vincent Haufroid, Laure Elens, et al.
Pharmacogenomics|October 24, 2014
Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohortMaja Matic, Elisabeth Norman, Anders Rane, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Pharmacogenetics and Genomics|September 22, 2007
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantationLaure Elens, Arnaud Capron, Valérie Van Kerckhove, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 30, 2020
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectivesAlexandra L Degraeve, Serge Moudio, Vincent Haufroid, et al.
Therapeutic Drug Monitoring|October 17, 2022
Genetic Polymorphisms in SLCO2B1 and ABCC1 Conjointly Modulate Atorvastatin Intracellular Accumulation in HEK293 Recombinant Cell LinesEmilia Hoste, Adrien Paquot, Nadtha Panin, et al.
Microbiome|July 5, 2023
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1Alexandra L Degraeve, Vincent Haufroid, Axelle Loriot, et al.
Scientific Reports|May 11, 2018
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patientsLeïla Belkhir, Carole Seguin-Devaux, Laure Elens, et al.
Pharmacogenomics|September 10, 2011
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patientsLaure Elens, Ron H van Schaik, Nadtha Panin, et al.
Pharmacogenomics|February 23, 2018
Detection of a rare CYP3A4 variant in a transplant patient characterized by a tacrolimus poor metabolizer phenotypeNuria Lloberas, Dennis A Hesselink, Ron Hn van Schaik, et al.
Clinical and Translational Science|November 11, 2021
Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical responseGabriel Stillemans, Adrien Paquot, Giulio G Muccioli, et al.
The Journal of Surgical Research|July 28, 2012
Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantationMartine De Meyer, Vincent Haufroid, Laure Elens, et al.
Pharmacogenomics|October 24, 2014
Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohortMaja Matic, Elisabeth Norman, Anders Rane, et al.
Pageof 9